Synthomer PLC - AGM trading statement
Synthomer plc
AGM 2026 trading statement
Strong H1 trading - market environment remains uncertain
Synthomer plc ('Synthomer' or 'the Group') today issues a scheduled update on trading since the start of 2026, ahead of today's Annual General Meeting (AGM). Results of voting at the AGM will be announced later today.
• On track to deliver strong H1 revenue, EBITDA and margin progress relative to prior year
• Improving trading momentum led by CCS from the start of the year, driven by targeted growth and cost savings
• Progress accelerated in Q2, reflecting Synthomer's robust positioning and pass-through pricing power in a fast-changing operating and commercial environment
• Successful debt refinancing in April provides strengthened financial position to focus on delivering further self-help and strategic transformation objectives, including further non-core divestments
• Expectations of year-on-year progress despite ongoing geopolitical and end-market uncertainties underpinned by the strong trading in H1, strategic delivery and continuing benefits from prior year 'self-help' cost actions
Trading performance
Synthomer achieved strong growth in Continuing Group volume, revenue, EBITDA and EBITDA margin in the first five months of 2026 compared with the equivalent prior year period. Overall trading in Q1 was in line with our expectations and ahead of prior year, with much-improved Coatings & Construction Solutions (CCS) and stable Adhesive Solutions (AS) performances offsetting a slower start in parts of the Health & Protection and Performance Materials (HPPM) division. Momentum improved for all three divisions through Q1, benefitting from some end-market growth and a combination of cost savings and targeted growth actions. These include disciplined investment in key market opportunities such as industrial coatings for data centres in CCS and additional APO capacity in AS.
Trading performance across the Group accelerated in April and May, reflecting substantial changes in our operating and commercial environment following the start of the
Financial position
Following the successful bank debt refinancing and maturity extension announced in
Outlook
The strong trading in H1, together with the continued benefits from prior year self-help actions in H2, underpin our confidence in delivering year-on-year progress in 2026. The geopolitical context remains volatile, making it difficult to predict the duration of current conditions or longer term end-market trends. We therefore continue to focus on delivering for customers and maintaining discipline around cost and capital allocation.
Synthomer's strategic priorities also remain unchanged. Last week we announced the divestment of the Acrylate Monomers business and we continue to progress other non-core divestment processes to accelerate the Group's deleveraging and simplify the business portfolio further.
Commenting, Synthomer CEO
"We are very pleased with how the business has performed so far in 2026, reflecting our sustained commitment to our strategic transformation, consistent focus on 'controlling the controllables', all accelerated in Q2 by our agility and ability to reliably deliver for our customers in the disrupted operating conditions resulting from the
Further information:
|
Investors: |
Tel: +44 (0) 1279 775 306 |
|
Media: |
Tel: +44 (0) 203 727 1340 |
Notes
Synthomer's 2026 AGM is taking place at
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection - growing markets for customers who serve billions of end users worldwide. Headquartered in
In Coatings & Construction Solutions, our specialist polymers enhance the sustainability and performance of a wide range of coatings and construction products. We serve customers in applications including architectural and masonry coatings, mortar modification, waterproofing and flooring, fibre bonding, and energy solutions. In Adhesive Solutions our products help our customers bond, modify and compatibilise surfaces and components for applications including tapes and labels, packaging, hygiene, tyres and plastic modification, improving permeability, strength, elasticity, damping, dispersion and grip. In Health & Protection and Performance Materials we are a world-leading supplier of water-based polymers for medical gloves, and a major European manufacturer of high-performance binders, foams and other products serving customers in a range of end markets.
Our purpose is creating innovative and sustainable solutions for the benefit of customers and society. Around 20% of our sales volumes are from new and patent protected products. At our innovation centres of excellence in the
Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE